DEVELOPING · Attributed source report · science · World

Trial results posted: A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

NULLPEN · Source published 11/9/2026, 12:00:00 AM UTC

ClinicalTrials.gov records the first posting of results for study NCT04294810 on 2026-11-09. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

The study findings have not been independently assessed by NULLPEN.

The source record

National Library of Medicine, National Institutes of Health

Source: ClinicalTrials.gov, National Library of Medicine, United States. Registry entries are filed by trial sponsors; the registry does not verify them.Retrieved 2026-11-09T18:20:26.647Z. Updated on NULLPEN 2026-11-09T18:20:28.147Z.Revision sha256:37a63e5af618c6b35fd7d33bfaab7fda7a49debb16a89e76a50c5cc02128d3a3